Literature DB >> 26036350

Predictors of Prolonged Hospital Length of Stay Following Stage II Palliation of Hypoplastic Left Heart Syndrome (and Variants): Analysis of the National Pediatric Cardiology Quality Improvement Collaborative (NPC-QIC) Database.

Carissa M Baker-Smith1, Sara W Goldberg2, Geoffrey L Rosenthal3.   

Abstract

The objective of this study is to identify predictors of prolonged hospital length of stay (LOS) for single ventricle patients following stage 2 palliation (S2P), excluding patients who underwent a hybrid procedure. We explore the impact of demographic features, stage 1 palliation (S1P), interstage I (IS1) management, S2P, and post-surgical care on hospital LOS following S2P. We conducted a retrospective analysis of the National Pediatric Cardiology Quality Improvement Collaborative (NPC-QIC) database. The NPC-QIC database is an established registry of patients with hypoplastic left heart syndrome (HLHS) and its variants. It contains detailed information regarding the demographic features, S1P, IS1, S2P, and interstage 2 (IS2) management of children with HLHS and related single ventricle cardiac malformations. Between 2008 and 2012, there were 477 participants with recorded LOS data in the NPC-QIC registry. Excluding the 29 patients who underwent hybrid procedure, there were 448 participants who underwent a Norwood (or Norwood-variant procedure) as S1P. In order to be included in the NPC-QIC database, participants were discharged to home following S1P and prior to S2P. We found that postoperative LOS among the 448 S2P procedure recipients is most strongly influenced by the need for reoperation following S2P, the need for an additional cardiac catheterization procedure following S2P, the use of non-oral methods of nutrition (e.g., nasogastric tube, total parental nutrition, gastrostomy tube), and the development of postoperative complications. Factors such as age at the time of S2P, the presence of a major non-cardiac anomaly, site participant volume, IS1 course, the type and number of vasoactive agents used following S2P, and the need for more than 1 intensive care unit (ICU) hospitalization (following discharge to the ward but prior to discharge to home) were significant predictors by univariate analysis but not by multivariate analysis. We excluded participants undergoing the hybrid procedure as S1P from this analysis given that the S2P following the initial hybrid is typically a more complicated procedure. Hospital LOS following S2P among children undergoing the Norwood or Norwood-variant procedure as S1P is most strongly influenced by events following S2P and not demographic or S1P factors. Factors most predictive of prolonged LOS include the need for reoperation, the need for an additional cardiac catheterization procedure following S2P, the need for non-oral methods of nutrition, and the development of postoperative complications.

Entities:  

Keywords:  Bidirectional Glenn procedure; Hospitalization; Hypoplastic left heart syndrome; Length of stay

Mesh:

Year:  2015        PMID: 26036350     DOI: 10.1007/s00246-015-1208-3

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  30 in total

1.  Outcomes of the bidirectional Glenn procedure in patients less than 3 months of age.

Authors:  Orlando Petrucci; Philip R Khoury; Peter B Manning; Pirooz Eghtesady
Journal:  J Thorac Cardiovasc Surg       Date:  2009-11-11       Impact factor: 5.209

2.  Hemi-Fontan procedure for hypoplastic left heart syndrome: outcome and suitability for Fontan.

Authors:  W I Douglas; C S Goldberg; R S Mosca; I H Law; E L Bove
Journal:  Ann Thorac Surg       Date:  1999-10       Impact factor: 4.330

3.  Interstage attrition between bidirectional Glenn and Fontan palliation in children with hypoplastic left heart syndrome.

Authors:  Waldemar F Carlo; Kathleen E Carberry; Jeffrey S Heinle; David L Morales; E Dean McKenzie; Charles D Fraser; David P Nelson
Journal:  J Thorac Cardiovasc Surg       Date:  2011-06-25       Impact factor: 5.209

4.  Surgical treatment for hypoplastic left heart syndrome.

Authors:  E L Bove
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-02

5.  Impact of noncardiac congenital and genetic abnormalities on outcomes in hypoplastic left heart syndrome.

Authors:  Angira Patel; Edward Hickey; Constantine Mavroudis; Jeffrey P Jacobs; Marshall L Jacobs; Carl L Backer; Melanie Gevitz; Constantine D Mavroudis
Journal:  Ann Thorac Surg       Date:  2010-06       Impact factor: 4.330

6.  Usefulness of the bidirectional Glenn procedure as staged reconstruction for the functional single ventricle.

Authors:  A K Pridjian; A M Mendelsohn; F M Lupinetti; R H Beekman; M Dick; G Serwer; E L Bove
Journal:  Am J Cardiol       Date:  1993-04-15       Impact factor: 2.778

7.  Early cavopulmonary anastomosis in very young infants after the Norwood procedure: impact on oxygenation, resource utilization, and mortality.

Authors:  Robert D B Jaquiss; Nancy S Ghanayem; George M Hoffman; Raymond T Fedderly; Joseph R Cava; Kathleen A Mussatto; James S Tweddell
Journal:  J Thorac Cardiovasc Surg       Date:  2004-04       Impact factor: 5.209

8.  Hybrid approach for hypoplastic left heart syndrome: intermediate results after the learning curve.

Authors:  Mark Galantowicz; John P Cheatham; Alistair Phillips; Clifford L Cua; Timothy M Hoffman; Sharon L Hill; Roberta Rodeman
Journal:  Ann Thorac Surg       Date:  2008-06       Impact factor: 4.330

9.  Outcomes after bidirectional Glenn operation: Blalock-Taussig shunt versus right ventricle-to-pulmonary artery conduit.

Authors:  Lillian Lai; Peter C Laussen; Clifford L Cua; David L Wessel; John M Costello; Pedro J del Nido; John E Mayer; Ravi R Thiagarajan
Journal:  Ann Thorac Surg       Date:  2007-05       Impact factor: 4.330

10.  Factors influencing survival in patients undergoing the bidirectional Glenn anastomosis.

Authors:  J C Alejos; R G Williams; J M Jarmakani; A J Galindo; J B Isabel-Jones; D Drinkwater; H Laks; S Kaplan
Journal:  Am J Cardiol       Date:  1995-05-15       Impact factor: 2.778

View more
  4 in total

1.  The Optimal Timing of Stage-2-Palliation After the Norwood Operation.

Authors:  James M Meza; Edward Hickey; Brian McCrindle; Eugene Blackstone; Brett Anderson; David Overman; James K Kirklin; Tara Karamlou; Christopher Caldarone; Richard Kim; William DeCampli; Marshall Jacobs; Kristine Guleserian; Jeffrey P Jacobs; Robert Jaquiss
Journal:  Ann Thorac Surg       Date:  2017-08-25       Impact factor: 4.330

Review 2.  Blood Versus Crystalloid Cardioplegia in Pediatric Cardiac Surgery: A Systematic Review and Meta-analysis.

Authors:  Konstantinos S Mylonas; Aspasia Tzani; Panagiotis Metaxas; Dimitrios Schizas; Vasileios Boikou; Konstantinos P Economopoulos
Journal:  Pediatr Cardiol       Date:  2017-09-25       Impact factor: 1.655

3.  Interstage Survival for Patients with Hypoplastic Left Heart Syndrome After ECMO.

Authors:  Richard P Fernandez; Brian F Joy; Robin Allen; Jamie Stewart; Holly Miller-Tate; Yongjie Miao; Lisa Nicholson; Clifford L Cua
Journal:  Pediatr Cardiol       Date:  2016-11-01       Impact factor: 1.655

Review 4.  Extracorporeal Membrane Oxygenation (ECMO) Support in Special Patient Populations-The Bidirectional Glenn and Fontan Circulations.

Authors:  Matthew K Bacon; Seth B Gray; Steven M Schwartz; David S Cooper
Journal:  Front Pediatr       Date:  2018-10-17       Impact factor: 3.418

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.